Allstate Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Allstate Investment Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$8.9M	Buy	+16,160	New	+$8.56M	0.27%	53

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allstate Investment Management's TMO Position: Q4 2022 in Review

Allstate Investment Management opened a new position in Thermo Fisher Scientific (TMO) in Q4 2022: 16,160 shares worth $8.9M. The stake represents 0.27% of the portfolio and ranks #53 among its holdings.

2,376 funds tracked by Wall St. Rank hold TMO as of Q4 2022.

Allstate Investment Management held 16,160 shares of Thermo Fisher Scientific worth $8.9M as of Q4 2022.
Thermo Fisher Scientific was a new Allstate Investment Management position in Q4 2022.
Thermo Fisher Scientific made up 0.27% of Allstate Investment Management's portfolio in Q4 2022, its #53 holding.
2,376 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2022.

Based on Allstate Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.